• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后子宫内膜的增殖活性:引发子宫内膜腺癌的潜在隐患。

Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.

作者信息

Sivridis E, Giatromanolaki A

机构信息

Department of Pathology, Democritus University of Thrace, Alexandroupolis 68100, Greece.

出版信息

J Clin Pathol. 2004 Aug;57(8):840-4. doi: 10.1136/jcp.2003.014399.

DOI:10.1136/jcp.2003.014399
PMID:15280405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1770392/
Abstract

AIMS

To investigate proliferation in disease free postmenopausal endometrium and that harbouring endometrial adenocarcinoma-is there a dynamic, yet lurking, potential for atrophic endometrium to give rise to endometrial adenocarcinoma?

MATERIAL/METHODS: The study comprised 84 disease free endometria from asymptomatic postmenopausal women who had undergone hysterectomy for prolapse, and 50 endometrioid cell type endometrial adenocarcinomas with adjacent uninvolved postmenopausal endometrium. The non-neoplastic tissues were separated histologically into active, inactive, and mixed forms, although only the first two categories were studied immunohistochemically for oestrogen and progesterone receptors (ERs, PRs), epidermal growth factor receptor (EGFR), Ki-67, and angiogenic activity.

RESULTS

All postmenopausal endometria were atrophic, but only 42 were inactive; of the remaining samples, 22 were weakly proliferative and 20 were mixed active and inactive. In contrast, the non-neoplastic component of 43 of the 50 endometrial adenocarcinomas examined was of the active form; four specimens were of the pure and 39 of the mixed form. Interestingly, high ER and PR expression was seen in active and inactive endometria, but only the former were EGFR positive and had high proliferative (Ki-67) and angiogenic activity. A similar trend was also shown by the non-neoplastic atrophic endometrium adjacent to endometrial adenocarcinoma.

CONCLUSIONS

At least half of the disease free postmenopausal atrophic endometria show a weak proliferative pattern, either diffuse or focal, probably as a response to continuous low level oestrogenic stimulation. These tissues have a latent, although very small, carcinogenic potential, as demonstrated by the immunohistochemical profile and their frequent association with adjacent endometrial adenocarcinoma.

摘要

目的

研究绝经后无病子宫内膜以及患有子宫内膜腺癌的子宫内膜的增殖情况——萎缩性子宫内膜是否存在动态但潜在的发展为子宫内膜腺癌的可能性?

材料/方法:本研究包括84例因子宫脱垂接受子宫切除术的无症状绝经后妇女的无病子宫内膜,以及50例子宫内膜样细胞型子宫内膜腺癌及其相邻未受累的绝经后子宫内膜。非肿瘤组织在组织学上分为活跃型、不活跃型和混合型,不过仅对前两类进行雌激素和孕激素受体(ERs、PRs)、表皮生长因子受体(EGFR)、Ki-67以及血管生成活性的免疫组织化学研究。

结果

所有绝经后子宫内膜均为萎缩性,但只有42例为不活跃型;其余样本中,22例轻度增殖,20例为活跃与不活跃混合型。相比之下,所检查的50例子宫内膜腺癌中,43例的非肿瘤成分呈活跃型;4例为纯活跃型,39例为混合活跃型。有趣的是,活跃型和不活跃型子宫内膜中均可见高ER和PR表达,但只有前者EGFR呈阳性且具有高增殖性(Ki-67)和血管生成活性。与子宫内膜腺癌相邻的非肿瘤性萎缩子宫内膜也呈现类似趋势。

结论

至少一半的绝经后无病萎缩性子宫内膜表现出轻度增殖模式,可为弥漫性或局灶性,这可能是对持续低水平雌激素刺激的反应。这些组织具有潜在的致癌可能性,尽管非常小,免疫组织化学特征及其与相邻子宫内膜腺癌的频繁关联证明了这一点。

相似文献

1
Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.绝经后子宫内膜的增殖活性:引发子宫内膜腺癌的潜在隐患。
J Clin Pathol. 2004 Aug;57(8):840-4. doi: 10.1136/jcp.2003.014399.
2
Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.子宫内膜透明细胞癌的特征在于p53、Ki-67、雌激素和孕激素受体表达的独特模式。
Hum Pathol. 1998 Jun;29(6):551-8. doi: 10.1016/s0046-8177(98)80002-6.
3
Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.复制许可因子MCM2和MCM3在正常、增生性及癌性子宫内膜中的表达:与Ki-67、雌激素及孕激素受体表达的相关性
Int J Gynecol Pathol. 2003 Oct;22(4):334-40. doi: 10.1097/01.pgp.0000092129.10100.5e.
4
Steroid receptor expression in endometria from women treated with tamoxifen.接受他莫昔芬治疗的女性子宫内膜中类固醇受体的表达
Gynecol Oncol. 1998 Aug;70(2):188-91. doi: 10.1006/gyno.1998.5087.
5
The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.他莫昔芬对绝经后子宫内膜增殖及类固醇受体表达的影响。
J Clin Pathol. 2002 Jul;55(7):514-9. doi: 10.1136/jcp.55.7.514.
6
[The relationship between the pathologic features of the uninvolved endometrium and prognosis in postmenopausal endometrial carcinoma].[绝经后子宫内膜癌未受累子宫内膜的病理特征与预后的关系]
Zhonghua Fu Chan Ke Za Zhi. 1997 Oct;32(10):605-8.
7
Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.心脏和神经嵴衍生表达转录本2(HAND2):一种用于识别非典型增生和I型子宫内膜癌的新型生物标志物。
Int J Gynecol Pathol. 2015 Jan;34(1):65-73. doi: 10.1097/PGP.0000000000000106.
8
Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.绝经后女性卵巢卵泡膜细胞增生症与子宫内膜息肉、子宫内膜增生及子宫内膜样腺癌的相关性:238例临床病理研究
Hum Pathol. 2017 Jan;59:120-124. doi: 10.1016/j.humpath.2016.09.021. Epub 2016 Oct 13.
9
Proliferation in Postmenopausal Endometrial Polyps-A Potential for Malignant Transformation.绝经后子宫内膜息肉的增生——恶性转化的潜在风险。
Medicina (Kaunas). 2019 Aug 28;55(9):543. doi: 10.3390/medicina55090543.
10
L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.L 型氨基酸转运蛋白 1 的表达在分化良好的子宫内膜样腺癌中增加,而在分化不良的子宫内膜样腺癌中减少,并与 p53 表达呈负相关。
Int J Gynecol Cancer. 2014 May;24(4):659-63. doi: 10.1097/IGC.0000000000000123.

引用本文的文献

1
Evaluation of morphology, apoptosis, and cell proliferation of the uterus in postmenopausal women.绝经后女性子宫形态、细胞凋亡及细胞增殖的评估。
Histol Histopathol. 2025 May;40(5):653-667. doi: 10.14670/HH-18-819. Epub 2024 Sep 23.
2
Proliferation in Postmenopausal Endometrial Polyps-A Potential for Malignant Transformation.绝经后子宫内膜息肉的增生——恶性转化的潜在风险。
Medicina (Kaunas). 2019 Aug 28;55(9):543. doi: 10.3390/medicina55090543.
3
Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors.人子宫内膜中的胰岛素/胰岛素样生长因子和性激素轴及其与子宫内膜癌危险因素的关联。
Cancer Causes Control. 2016 Jun;27(6):737-48. doi: 10.1007/s10552-016-0751-4. Epub 2016 Apr 28.
4
Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival.雄激素受体由健康的绝经后子宫内膜上皮获得,其在子宫内膜癌中的随后丧失与较差的生存率相关。
Br J Cancer. 2016 Mar 15;114(6):688-96. doi: 10.1038/bjc.2016.16. Epub 2016 Mar 1.
5
Spontaneous Reproductive Tract Lesions in Aged Captive Chimpanzees.圈养老年黑猩猩的自发性生殖道病变
Vet Pathol. 2016 Mar;53(2):425-35. doi: 10.1177/0300985815620654. Epub 2016 Jan 28.
6
Effect of hormone replacement therapy on postmenopausal endometrial bleeding.激素替代疗法对绝经后子宫内膜出血的影响。
Pathol Oncol Res. 2007;13(4):351-9. doi: 10.1007/BF02940316. Epub 2007 Dec 25.

本文引用的文献

1
Pre-menopausal cystic hyperplasia and endometrial carcinoma.
J Obstet Gynaecol Br Emp. 1959 Apr;66(2):288-96. doi: 10.1111/j.1471-0528.1959.tb02009.x.
2
The mitogenic potential of heparin-binding epidermal growth factor in the human endometrium is mediated by the epidermal growth factor receptor and is modulated by tumor necrosis factor-alpha.肝素结合表皮生长因子在人子宫内膜中的促有丝分裂潜能由表皮生长因子受体介导,并受肿瘤坏死因子-α调节。
J Clin Endocrinol Metab. 2002 Dec;87(12):5769-77. doi: 10.1210/jc.2002-020069.
3
Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?浆液性乳头状/透明细胞型I-II期子宫内膜癌与国际妇产科联盟(FIGO)3级子宫内膜样癌的预后是否存在差异?
Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):79-85. doi: 10.1016/s0360-3016(02)02913-9.
4
The endocrinology of menstruation--a role for the immune system.月经内分泌学——免疫系统的作用
Clin Endocrinol (Oxf). 2001 Dec;55(6):701-10. doi: 10.1046/j.1365-2265.2001.01432.x.
5
Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy.血管内皮生长因子(VEGF)及其受体在人类子宫内膜整个月经周期及妊娠早期的表达。
Reproduction. 2002 Mar;123(3):379-87. doi: 10.1530/rep.0.1230379.
6
Prognostic aspects on endometrial hyperplasia and neoplasia.子宫内膜增生和肿瘤形成的预后因素
Virchows Arch. 2001 Aug;439(2):118-26. doi: 10.1007/s004280100418.
7
Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression.子宫内膜癌:类固醇激素受体表达与低血管生成及bcl-2表达的关联
Virchows Arch. 2001 May;438(5):470-7. doi: 10.1007/s004280000361.
8
Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium.雌激素受体β存在于人类和非人类灵长类动物子宫内膜的血管内皮中,而雌激素受体α则不存在。
J Clin Endocrinol Metab. 2001 Mar;86(3):1370-8. doi: 10.1210/jcem.86.3.7317.
9
Thymidine phosphorylase expression in normal and hyperplastic endometrium.胸苷磷酸化酶在正常及增生期子宫内膜中的表达。
J Clin Pathol. 2000 Sep;53(9):704-8. doi: 10.1136/jcp.53.9.704.
10
Epidermal growth factor receptor immunostaining and epidermal growth factor receptor-tyrosine kinase activity in proliferative and neoplastic human endometrium.
Tumour Biol. 2000 Nov-Dec;21(6):358-66. doi: 10.1159/000030141.